Cargando…
Serum complement C3 and α(2)-macroglobulin are potentially useful biomarkers for inflammatory bowel disease patients
AIMS: Ulcerative colitis (UC), characterized by chronic inflammation and its recurrence in the large intestine, is well known as inflammatory bowel disease (IBD). Suitable biomarkers specific for UC are poorly understood till date. We aimed to discover novel serum biomarkers for UC and identify good...
Autores principales: | Okada, Kohki, Itoh, Hiroshi, Ikemoto, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022144/ https://www.ncbi.nlm.nih.gov/pubmed/33851052 http://dx.doi.org/10.1016/j.heliyon.2021.e06554 |
Ejemplares similares
-
Circulating S100A8/A9 is potentially a biomarker that could reflect the severity of experimental colitis in rats
por: Okada, Kohki, et al.
Publicado: (2020) -
Carbonic Anhydrase III Has Potential as a Biomarker for Experimental Colitis and Functions as an Immune Regulator by Inhibiting Inflammatory Cytokine Secretion
por: Okada, Kohki, et al.
Publicado: (2022) -
Conformational States of a Bacterial α(2)-Macroglobulin Resemble Those of Human Complement C3
por: Neves, David, et al.
Publicado: (2012) -
Molecular form and concentration of serum α(2)-macroglobulin in diabetes
por: Yoshino, Sonomi, et al.
Publicado: (2019) -
A New Hybrid Protein Is a Novel Regulator for Experimental Colitis in Rats
por: Okada, Kohki, et al.
Publicado: (2021)